CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Fish oil (Dry n-3, BASF)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00266305
NCT00266305N/ACompleted
CompareCT.gov

Fish Oil Supplementation in Lactation

University of Copenhagen·interventional·Posted Dec 16, 2005·Updated Aug 14, 2008

In Brief

A clinical study evaluating Fish oil (Dry n-3, BASF) for Development and Health. Completed, across 1 site.

Detailed Summary

The main purpose of the study was to examine whether fish oil supplementation of lactating mothers affect infant development during first year of life, focusing on visual and mental development. A follow-up studies are conducted in order to see if early intake of long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) have any long-term effects on health, primarily immun function and markers of cardiovascular risk.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDevelopment and Health
CountriesDenmark
CollaboratorsDanish Research Agency, BASF, Technical University of Denmark

Timeline

N/ACompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 16, 2005
Enrollment StartDec 1, 1998
Study CompletionJan 1, 2007
TodayJul 2, 2026
Posted 20.5 years ago

Interventions

Fish oil (Dry n-3, BASF)behavioral

5 g/oil daily for the first four month of lactation